Who is sponsoring NCT02236676?

NCT02236676 is sponsored by Kessler Foundation.

What drugs are being tested in NCT02236676?

Interventions in NCT02236676: Nap after rehearsal trials.

What condition does NCT02236676 study?

NCT02236676 studies Motor Learning in TBI.

Is NCT02236676 still recruiting?

NCT02236676 is currently completed. Last updated 5 September 2021.

Last reviewed 2021-09-05 · How we verify

NCT02236676

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sleep Study Among Inpatients With TBI in an Acute Rehabilitation Hospital

Completed NA Last updated 5 September 2021

What this trial tests

NA trial testing Nap after rehearsal trials in Motor Learning in TBI in 5 participants. Completed in 31 May 2019.

Timeline

28 May 2014

Primary endpoint
31 May 2019

31 May 2019

Quick facts

Lead sponsor	Kessler Foundation
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	5
Start date	28 May 2014
Primary completion	31 May 2019
Estimated completion	31 May 2019
Sites	1 location across United States

Drugs / interventions tested

Nap after rehearsal trials

Conditions studied

Motor Learning in TBI — all drugs for Motor Learning in TBI →

Sponsor

Kessler Foundation

Who can join

Adults 18 to 65, any sex, with Motor Learning in TBI. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to better understand how a daytime nap after training on a motor skill after brain injury improves performance compared with the same amount of time after training spent awake and resting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Kessler Foundation trials

Trials by the same sponsor.

NCT07168941 — Evaluation and Refinement of KF-STRIDE Into the Interview! · NA · not yet recruiting
NCT07159100 — tDCS for Cancer-Related Fatigue and Weakness · EARLY_PHASE1 · not yet recruiting
NCT06886152 — Spinal Stimulation and Gait Training to Improve Mobility in TBI · NA · not yet recruiting
NCT07073313 — Using Muscle Functional MRI to Study Spatial Muscle Activation Patterns in People With SCI · not yet recruiting
NCT06923293 — Improving Walking After a Lower Limb Injury Using a Custom Motorized Orthosis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02236676 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kessler Foundation
Last refreshed: 5 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02236676.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing